The FDA is warning patients and healthcare professionals about the potential for rare but serious adverse events associated with injection of corticosteroids into the epidural space of the spine.
Hospira announced a voluntary nationwide recall of one lot of 0.25% Marcaine (bupivacaine HCl) injection, single-dose 10mL vials due to discolored solution with visible particles embedded in the glass as well as the presence of discolored solution.
Hospira has initiated a voluntary recall of one lot of Lidocaine HCl injection 1%, 10mg/mL, single-dose 30mL vials due to an orange and black particulate found within the solution and embedded within the glass vial.
Cubist Pharmaceuticals announced a voluntary recall of one lot of Cubicin (daptomycin for injection) 500mg in 10mL vials, following a consumer complaint of particulate matter.
Nature's Universe announced a voluntary recall of all lots of old Thinogenics product due to the presence of an undisclosed ingredient, to the user level.
The FDA announced a nationwide recall of seven lots of Propofol Injectable Emulsion 1% (Hospira), due to visible metal particles embedded in the glass to the user level.
The FDA is discouraging the use of laparoscopic power morcellation for the removal of the uterus or uterine fibroids in women based on a recent analysis of currently available data.
The FDA has warned consumers that the sexual enhancement supplement S.W.A.G. contains an undisclosed ingredient and should not be purchased or used.
The FDA is advising consumers to not buy or use Infinity capsules or Lite Fit USA softgels, products that are marketed and sold for weight loss.
The FDA is warning consumers to avoid using or purchasing the herbal weight loss product New You after a laboratory analysis discovered undeclared sibutramine and phenolphthalein.